MicroVision, Inc. (NASDAQ: MVIS) today announced the closing of its public offering of 17,948,716 shares of its common stock and warrants to purchase 8,974,358 shares of its common stock at a price to the public of $0.585 per share and accompanying warrant, as well as warrants to purchase 1,251,092 additional shares sold upon exercise by the underwriter of its over-allotment option. MicroVision received net proceeds, after deducting the underwriting discount and estimated offering expenses, of approximately $9.8 million from the offering. Oppenheimer & Co. Inc. acted as underwriter for the offering. MicroVision intends to use the net proceeds of the offering for general corporate purposes. The securities described above were offered by MicroVision pursuant to its registration statement on Form S-3 that was previously filed and declared effective by the Securities and Exchange Commission (SEC). This press release does not constitute an offer to sell or a solicitation of an offer to buy the securities in the offering. The offering may be made only by means of the prospectus supplement and the prospectus relating to the proposed offering, copies of which may be obtained, when available, from Oppenheimer & Co. Inc., Attention: Syndicate Prospectus Department, 300 Madison Avenue, 4th Floor, New York, NY, 10017, by telephone at (212) 667-8563, or via email at EquityProspectus@opco.com. About MicroVision MicroVision provides the PicoP® display technology platform designed to enable next-generation display and imaging products for pico projectors, vehicle displays and wearable displays that interface with mobile devices. The company’s projection display engine uses highly efficient laser light sources that create vivid images with high contrast and brightness. For more information, visit us on: Website: www.microvision.com Blog: www.microvision.com/displayground Twitter: www.twitter.com/microvision Facebook: www.facebook.com/MicrovisionInc YouTube: www.youtube.com/mvisvideo Forward-looking Statements Certain statements contained in this release, including those relating to closing of the offering, and those statements using words such as “expects”, “intends”, “plans”, “should”, “would”, “will” and “believe” are forward-looking statements that involve a number of risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These risks and uncertainties include, but are not limited to, our ability to successfully complete the offering on terms and conditions satisfactory to us and the possible adverse impact on the market price of our shares of common stock due to the dilutive effect of the securities to be sold in the offering, as well as other risks and uncertainties, including those detailed from time to time in our SEC filings, including our Annual Report on Form 10-K and Quarterly Report on Form 10-Q. Except as expressly required by federal securities laws, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changes in circumstances or any other reason.
Additional InformationAdditional information relating to MicroVision can be found on EDGAR at www.sec.gov.